BNT327 1-15, BNT327, BNT326
BNT326-01
Phase 2 small_molecule active
Quick answer
BNT327 1-15, BNT327, BNT326 for Advanced solid tumors is a Phase 2 program (small_molecule) at BioNTech Manufacturing GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BioNTech Manufacturing GmbH
- Indication
- Advanced solid tumors
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active